Skip to main content
Caplight Logo









GT Metabolic Solutions

GT Metabolic Solutions

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://gtmetabolic.com/

Last Round

Series B

Mar 20, 2024

Total Funding Raised

$32.1M

Company Overview

GT Metabolic Solutions is a medical device company that develops magnetic compression anastomosis technologies for minimally invasive bariatric, metabolic, and digestive surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

magnetic compression anastomosisminimally invasive surgerybariatric surgeryincisionless surgerysutureless surgerymedical devicegastrointestinal surgeryanastomosismetabolic surgerykeyhole surgerysurgical toolsstaple-free surgerynatural orifice surgeryNOTES

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GT Metabolic Solutions Comparables

Compare GT Metabolic Solutions with similar companies based on industry and business-model similarity.

GT Metabolic Solutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GI Windows Surgical
90%
Nitinotes Ltd.
78%
USGI Medical
75%

GT Metabolic Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 20, 2024
Series BNov 6, 2023
Series AJul 18, 2022

Key People

Founding team and executive leadership

Thierry Thaure

Chief Executive Officer

Executive Team

GT Metabolic Solutions Investors

Notable investors and investment history

GT Metabolic Solutions investors
InvestorRounds
HealthTech CapitalSeries B
Krillion VenturesSeries B
Ceros Capital MarketsSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2024

    $25M round completed.

  • Jul 18, 2022

    $15M round led by Ceros Capital Markets.

GT Metabolic Solutions Filings

Explore SEC and related filing metadata, where available.

GT Metabolic Solutions filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GT Metabolic Solutions's valuation, stock price, and market status.

Is GT Metabolic Solutions a public or private company?

GT Metabolic Solutions is a private company.

What is the current stock price of GT Metabolic Solutions?

GT Metabolic Solutions is a private company with no public stock price. No recent secondary market data is available.

How much is GT Metabolic Solutions worth (valuation)?

Valuation information for GT Metabolic Solutions is not publicly available.

Can I buy GT Metabolic Solutions stock?

GT Metabolic Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GT Metabolic Solutions's last funding round?

GT Metabolic Solutions's most recent funding round was Series B on November 6, 2023.

Who are the main investors in GT Metabolic Solutions?

Key investors in GT Metabolic Solutions include Ceros Capital Markets.

Will GT Metabolic Solutions IPO soon?

No public IPO plans have been announced for GT Metabolic Solutions.

How can I track GT Metabolic Solutions secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GT Metabolic Solutions's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range26
Year Founded2020
Last FundingMar 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?